Literature DB >> 26629079

Myocardial ischemic post-conditioning attenuates ischemia reperfusion injury via PTEN/Akt signal pathway.

Chun-Mei Li1, Shu-Wen Shen1, Tao Wang2, Xing-Hua Zhang1.   

Abstract

OBJECTIVES: To investigate whether myocardial ischemic post-conditioning attenuates ischemia reperfusion injury via PTEN/Akt signal pathway.
DESIGN: Forty-five male Sprague-Dawley rats were randomly divided into three groups: Sham, Ischemia reperfusion (I/R) and Ischemic post-conditioning (IPost) group. After the experiment finished, myocardial infarction area was examined. Serum creatine phosphokinase and lactate dehydrogenase activity were detected at baseline and the end of reperfusion. The protein levels of PTEN, Akt, p-Akt, Bax and Bcl-2 were measured by Western blot method.
RESULTS: Myocardial infarct size was significantly reduced in IPost as compared to I/R. Results were confirmed by serum creatine phosphokinase and lactate dehydrogenase activity. In addition, PTEN and Bax protein expression were inhibited and the p-Akt and bcl-2 protein expression were enhanced in IPost compared with I/R (P < 0.05). At the same time, the ratio of Bax and Bcl-2 was decreased in IPost (P < 0.05). However, ischemic post conditioning did not affect the total Akt level (P > 0.05).
CONCLUSIONS: We confirmed that ischemic post-conditioning protects the heart against reperfusion injury. It is important that we demonstrated that the cardioprotective effect of ischemic post-conditioning was involved in the inhibition of PTEN, activation of the PI3K/Akt pathway and reduction of the cardiomyocyte apoptosis.

Entities:  

Keywords:  Akt; PTEN; apoptosis; ischemia reperfusion injury; post-conditioning

Year:  2015        PMID: 26629079      PMCID: PMC4658968     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

Review 1.  Phosphoinositide 3-kinases as targets for therapeutic intervention.

Authors:  Reinhard Wetzker; Christian Rommel
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

2.  Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.

Authors:  Takayuki Miki; Tetsuji Miura; Masaya Tanno; Masahiro Nishihara; Kazuyuki Naitoh; Takahiro Sato; Akari Takahashi; Kazuaki Shimamoto
Journal:  Basic Res Cardiol       Date:  2006-09-01       Impact factor: 17.165

Review 3.  Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.

Authors:  Donald M Lloyd-Jones; Yuling Hong; Darwin Labarthe; Dariush Mozaffarian; Lawrence J Appel; Linda Van Horn; Kurt Greenlund; Stephen Daniels; Graham Nichol; Gordon F Tomaselli; Donna K Arnett; Gregg C Fonarow; P Michael Ho; Michael S Lauer; Frederick A Masoudi; Rose Marie Robertson; Véronique Roger; Lee H Schwamm; Paul Sorlie; Clyde W Yancy; Wayne D Rosamond
Journal:  Circulation       Date:  2010-01-20       Impact factor: 29.690

Review 4.  Myocardial ischemia reperfusion injury: from basic science to clinical bedside.

Authors:  Anja Frank; Megan Bonney; Stephanie Bonney; Lindsay Weitzel; Michael Koeppen; Tobias Eckle
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2012-02-23

5.  PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning.

Authors:  Zheqing Cai; Gregg L Semenza
Journal:  Circ Res       Date:  2005-11-10       Impact factor: 17.367

6.  Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.

Authors:  Michael A Crackower; Gavin Y Oudit; Ivona Kozieradzki; Renu Sarao; Hui Sun; Takehiko Sasaki; Emilio Hirsch; Akira Suzuki; Tetsuo Shioi; Junko Irie-Sasaki; Rajan Sah; Hai-Ying M Cheng; Vitalyi O Rybin; Giuseppe Lembo; Luigi Fratta; Antonio J Oliveira-dos-Santos; Jeffery L Benovic; C Ronald Kahn; Seigo Izumo; Susan F Steinberg; Matthias P Wymann; Peter H Backx; Josef M Penninger
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

Review 7.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

Review 8.  PTENless means more.

Authors:  Bangyan Stiles; Matthias Groszer; Shunyou Wang; Jing Jiao; Hong Wu
Journal:  Dev Biol       Date:  2004-09-15       Impact factor: 3.582

9.  Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.

Authors:  Gavin Y Oudit; Zamaneh Kassiri; Joyce Zhou; Qiao C Liu; Peter P Liu; Peter H Backx; Fayez Dawood; Michael A Crackower; James W Scholey; Josef M Penninger
Journal:  Cardiovasc Res       Date:  2008-02-15       Impact factor: 10.787

10.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.

Authors:  Zhi-Qing Zhao; Joel S Corvera; Michael E Halkos; Faraz Kerendi; Ning-Ping Wang; Robert A Guyton; Jakob Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08       Impact factor: 4.733

View more
  11 in total

1.  Vitexin exerts cardioprotective effect on chronic myocardial ischemia/reperfusion injury in rats via inhibiting myocardial apoptosis and lipid peroxidation.

Authors:  Xia Che; Xin Wang; Junyan Zhang; Chengfeng Peng; Yilan Zhen; Xu Shao; Gongliang Zhang; Liuyi Dong
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

2.  Osthole attenuates myocardial ischemia/reperfusion injury in rats by inhibiting apoptosis and inflammation.

Authors:  Jingguo Wu; Yang Yang; Nan Xun; Lijin Zeng; Zhenyu Li; Wen Yang; Yanbing Liang; Zhongfu Ma; Hao Tang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 3.  Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart.

Authors:  Bartosz Walkowski; Marcin Kleibert; Miłosz Majka; Małgorzata Wojciechowska
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

4.  QSKL protects against myocardial apoptosis on heart failure via PI3K/Akt-p53 signaling pathway.

Authors:  Hong Chang; Chun Li; Qiyan Wang; Linghui Lu; Qian Zhang; Yi Zhang; Na Zhang; Yong Wang; Wei Wang
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

5.  The Effects of Potassium Cyanide on the Functional Recovery of Isolated Rat Hearts after Ischemia and Reperfusion: The Role of Oxidative Stress.

Authors:  Anica M Petkovic; Vladimir Lj Jakovljevic; Jovana V Bradic; Jovana N Jeremic; Nevena S Jeremic; Tamara R Nikolic Turnic; Nemanja U Jovicic; Vesna Z Rosic; Ivan M Srejovic; Vladimir I Zivkovic
Journal:  Oxid Med Cell Longev       Date:  2018-07-19       Impact factor: 6.543

6.  MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN.

Authors:  Zun-Ping Ke; Peng Xu; Yan Shi; Ai-Mei Gao
Journal:  Oncotarget       Date:  2016-05-17

7.  miR-19a protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis via PTEN/PI3K/p-Akt pathway.

Authors:  Guochao Sun; Ying Lu; Yingxia Li; Jun Mao; Jun Zhang; Yanling Jin; Yan Li; Yan Sun; Lei Liu; Lianhong Li
Journal:  Biosci Rep       Date:  2017-12-05       Impact factor: 3.840

8.  Remote post-conditioning and allopurinol reduce ischemia-reperfusion injury in an infra-renal ischemia model.

Authors:  Rafael Inácio Brandão; Ricardo Zanetti Gomes; Luana Lopes; Filipe Silva Linhares; José Carlos Rebuglio Vellosa; Katia Sabrina Paludo
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-10-08

9.  Selective Inhibition of PKCβ2 Restores Ischemic Postconditioning-Mediated Cardioprotection by Modulating Autophagy in Diabetic Rats.

Authors:  Yafeng Wang; Lu Zhou; Wating Su; Fengnan Huang; Yuan Zhang; Zhong-Yuan Xia; Zhengyuan Xia; Shaoqing Lei
Journal:  J Diabetes Res       Date:  2020-04-03       Impact factor: 4.011

10.  Ischaemic post-conditioning in rats: Responder and non-responder differ in transcriptome of mitochondrial proteins.

Authors:  Rolf Schreckenberg; Johann Klein; Hanna Sarah Kutsche; Rainer Schulz; Kamilla Gömöri; Péter Bencsik; Bettina Benczik; Bence Ágg; Éva Sághy; Péter Ferdinandy; Klaus-Dieter Schlüter
Journal:  J Cell Mol Med       Date:  2020-04-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.